Leserbrief
Hormone/HER2 receptor crosstalk in breast cancer needs further investigation
Medical Oncology · 2024
DOI: 10.1007/s12032-024-02383-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Medical Oncology, 2024. Verfasst von Kadri Altundag. Beteiligte Einrichtung: MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansFemaleReceptors, EstrogenReceptors, ProgesteroneReceptor Cross-Talk
Substanzen
Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesterone
Autor:innen und Institutionen
- MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com.
Zitieren
APA
Altundag, K. (2024). Hormone/HER2 receptor crosstalk in breast cancer needs further investigation. Medical Oncology. https://doi.org/10.1007/s12032-024-02383-9
Vancouver
Altundag K. Hormone/HER2 receptor crosstalk in breast cancer needs further investigation. Medical Oncology. 2024. doi:10.1007/s12032-024-02383-9
BibTeX
@article{Altundag2024,
author = {Altundag, Kadri},
title = {Hormone/HER2 receptor crosstalk in breast cancer needs further investigation},
journal = {Medical Oncology},
year = {2024},
doi = {10.1007/s12032-024-02383-9}
}
EUVIMED